{{Rsnum
|rsid=596359
|Chromosome=6
|position=153135918
|Orientation=plus
|GMAF=0.4674
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.6 | 45.1 | 21.2
| HCB | 7.4 | 35.3 | 57.4
| JPT | 5.3 | 42.5 | 52.2
| YRI | 49.3 | 38.4 | 12.3
| ASW | 42.1 | 38.6 | 19.3
| CHB | 7.4 | 35.3 | 57.4
| CHD | 4.6 | 33.9 | 61.5
| GIH | 5.9 | 38.6 | 55.4
| LWK | 33.6 | 54.5 | 11.8
| MEX | 25.9 | 48.3 | 25.9
| MKK | 50.6 | 40.4 | 9.0
| TSI | 25.5 | 45.1 | 29.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22591552
|Title=Variation in regulator of G-Protein signaling 17 Gene (RGS17) is associated with multiple substance dependence diagnoses
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}